In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy

被引:0
|
作者
Maria Pennuto
Manuela Basso
机构
[1] University of Trento,Dulbecco Telethon Institute Lab of Neurodegenerative Diseases, Centre for Integrative Biology (CIBIO)
[2] University of Trento,Laboratory of Transcriptional Neurobiology, Centre for Integrative Biology (CIBIO)
来源
Journal of Molecular Neuroscience | 2016年 / 58卷
关键词
Spinal and bulbar muscular atrophy; Androgen receptor; Cell models; Neuronal cells; Muscle cells; Mouse models; Transgenic mice; Knock-in mice;
D O I
暂无
中图分类号
学科分类号
摘要
Spinal and bulbar muscular atrophy (SBMA) is an X-linked neuromuscular disease characterized by late-onset, progressive degeneration of lower motor neurons and skeletal muscle atrophy. SBMA is caused by expansions of a CAG trinucleotide repeat in the gene encoding the androgen receptor (AR). One striking feature of SBMA is sex specificity: SBMA fully manifests only in males, whereas females show subclinical or mild disease manifestations even when homozygous for the mutation. Since the identification of the mutation responsible for SBMA in 1991, several cell and animal models have been developed to recapitulate the main features of disease in vitro and in vivo. In this review, we describe the most widely used cellular and animal models of SBMA, highlighting advantages and disadvantages in the use of these models to gain mechanistic and therapeutic insights into SBMA.
引用
收藏
页码:365 / 373
页数:8
相关论文
共 50 条
  • [1] In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy
    Pennuto, Maria
    Basso, Manuela
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 365 - 373
  • [2] Spinal and Bulbar Muscular Atrophy
    Grunseich, Christopher
    Fischbeck, Kenneth H.
    NEUROLOGIC CLINICS, 2015, 33 (04) : 847 - +
  • [3] Spinal and Bulbar Muscular Atrophy Overview
    Fischbeck, Kenneth H.
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2016, 58 (03) : 317 - 320
  • [4] Spinal and Bulbar Muscular Atrophy Overview
    Kenneth H. Fischbeck
    Journal of Molecular Neuroscience, 2016, 58 : 317 - 320
  • [5] The role of ubiquitination in spinal and bulbar muscular atrophy
    Sengupta, Medha
    Pluciennik, Anna
    Merry, Diane E.
    FRONTIERS IN MOLECULAR NEUROSCIENCE, 2022, 15
  • [6] No evidence of cardiomyopathy in spinal and bulbar muscular atrophy
    Querin, G.
    Melacini, P.
    D'Ascenzo, C.
    Morandi, L.
    Mazzini, L.
    Silani, V.
    Romito, S.
    Mandrioli, J.
    Raimondi, M.
    Pegoraro, E.
    Soraru', G.
    ACTA NEUROLOGICA SCANDINAVICA, 2013, 128 (06): : E30 - E32
  • [7] Developing treatment for spinal and bulbar muscular atrophy
    Fischbeck, Kenneth H.
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 257 - 261
  • [8] Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA)
    Katsuno, Masahisa
    Tanaka, Fumiaki
    Adachi, Hiroaki
    Banno, Haruhiko
    Suzuki, Keisuke
    Watanabe, Hirohisa
    Sobue, Gen
    PROGRESS IN NEUROBIOLOGY, 2012, 99 (03) : 246 - 256
  • [9] Neurotoxic effects of androgens in spinal and bulbar muscular atrophy
    Parodi, Sara
    Pennuto, Maria
    FRONTIERS IN NEUROENDOCRINOLOGY, 2011, 32 (04) : 416 - 425
  • [10] New Routes to Therapy for Spinal and Bulbar Muscular Atrophy
    Rocchi, Anna
    Pennuto, Maria
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2013, 50 (03) : 514 - 523